cambridge's bluebird bio licenses delivery tech to novartis, gsk..

fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and.

poor air quality is not unique to the uk or europe. more than 90% of people around the world breathe dangerous levels of air pollution, according to the. april 2006  (17).jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies..

. fueled by low vaccination rates led to 9,000 sick children and 10 infant deaths.